Musculoskeletal Diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women, between 40 and 65 years of age; diagnosis of chronic Plantar Fasciitis with a minimum duration of symptoms of four months; with unilateral or bilateral pain; who present pain of at least three on the numerical pain scale; pain at the insertion of the plantar fascia, especially with the first steps in the morning and after a period of rest without weight bearing; pain at the insertion of the plantar fascia, after more intense physical activity with weight bearing; pain on palpation at the insertion of the plantar fascia at the medial tubercle of the calcaneus; positive Windlass test; individuals who are able to be accompanied by a close relative or friend, of legal age, throughout the participant's remote intervention period
Exclusion criteria
Exclusion criteria: Differential diagnoses for Plantar Fasciitis, such as Atrophy of the heel fat pad and proximal plantar fibromatosis; injuries and/or trauma to the lower limbs that have occurred less than six months ago; previous surgery to the lower limbs; conditions that prevent the performance of physical exercise such as neurological, cardiovascular, orthopedic or rheumatological diseases; pregnancy; those who are undergoing any treatment for Plantar Fasciitis and/or regular activities that involve Pilates exercises
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess foot function using the Pain Numerical Rating Scale at baseline and after eight weeks of treatment after randomization.;To assess foot function using the Foot Function Index (FFI) questionnaire at baseline and after eight weeks of treatment after randomization. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess foot pain using the Numerical Pain Rating Scale (NPS) at the 12th and 24th week follow-up after randomization.;To assess foot function using the Foot Function Index (FFI) questionnaire at the 12th and 24th week follow-up after randomization.;To assess kinesiophobia using the Tampa Kinesiophobia Scale (TSK) at the beginning of treatment, after eight weeks of treatment and at the 12th and 24th week follow-up after randomization.;To assess the presence of catastrophic thoughts about pain using The Pain Catastrophizing Scale (PCS) at the beginning of treatment, after eight weeks of treatment and at the 12th and 24th week follow-ups after randomization.;TTo assess the participants' level of perceived recovery in relation to the intervention using the Global Rating of Change Scales (GPE) at the beginning of treatment, after eight weeks of treatment and at the 12th and 24th week follow-up after randomization. | — |
Countries
Brazil
Contacts
Universidade Federal de São Paulo